The intensity of PPARγ within infiltrating macrophages was associated with better prognosis though without statistical significance, indicating that PPARγ activation in hepatic infiltrating macrophages potentially benefits HCC patients. This evidence concerns the gene PPARG and hepatocellular carcinoma.